Dr. Sharpe's functional analysis
of costimulatory pathways regulating T cell activation has led to understanding of (1) the roles of B7 - 1 and B7 - 2 as positive regulators through CD28 and (2) negative regulators through CTLA - 4, and (3) the role of PD - L1 and PD - L2 as negative regulators through PD - 1.
These include T - cell depletion by apoptosis; anergy (ie, the process by which T cells that are presented with a peptide in the absence
of costimulatory signals become refractory to further stimulation with the antigen and are therefore inactivated); and the development of regulatory T cells, which can actively suppress antigen - specific responses following re-challenge with the antigen.
When TLRs are triggered by lipopolysaccharides, oral Langerhans cells upregulate expression of coinhibitory molecules B7 - H1 and B7 - H3, whereas expression
of the costimulatory molecule CD86 (B7 - 2) is decreased.
Upregulation
of costimulatory molecules induced by lipopolysaccharide and double - stranded RNA occurs by Trif - dependent and Trif - independent pathways.
The role
of costimulatory signals in T cell induction was evaluated in mice lacking the interleukin - 2 (IL - 2) gene.
Formation
of the costimulatory axis was already known to be important for a full immune response, but the present findings propel this axis to the foreground as a key bottleneck.
Not exact matches
Thus, transport
of peptide — MHC II complexes by DCs not only accomplishes transfer from late endocytic compartments to the plasma membrane, but does so in a manner that selectively concentrates TCR ligands and
costimulatory molecules for T cell contact.
Insight into this mechanism led the researchers to design new peptides — snippets
of the human B7 - 2 receptor protein — that powerfully block the binding
of a superantigen to its
costimulatory receptor targets, and thereby protect against lethal toxic shock, as they showed in animals.
Newly - discovered mechanism
of action
of the bacterial superantigen toxins: Superantigens bind to both B7 - 2 and CD28, the major
costimulatory receptors expressed on human immune cells.
Because previous work in rats and monkeys has found that proteins that block the
costimulatory signal can hold T cells at bay, Kim Olthoff, a transplant surgeon at the University
of Pennsylvania Medical Center in Philadelphia, thought her team could achieve a targeted immune suppression by getting the transplanted organ itself — rather than proteins injected into the bloodstream — to block the
costimulatory signal.
But before immune - system fighters called T cells will attack foreign tissue, they must first get a confirmation order
of sorts: a
costimulatory signal.
Single - cell differential gene expression analysis revealed a spectrum
of known transcripts, including several linked to cytotoxic and
costimulatory function that are expressed at higher levels in the TEMRA (effector memory T cells expressing CD45RA) subset, which is highly enriched for CD4 - CTLs, compared with CD4 + T cells in the central memory (TCM) and effector memory (TEM) subsets.
B7h, a novel
costimulatory homolog
of B7.
Decreased expression
of B7
costimulatory molecules and major histocompatibility complex class - I in human hepatocellular carcinoma.
Costimulatory members
of the TNFR family: Keys to Effective T cell immunity.
Initial studies demonstrated that ligation
of 4 - 1BB on T cells could deliver
costimulatory signals resulting in either increased proliferation or enhanced cytokine secretion and also control clonal expansion and differentiation
of effector and memory T cells.
Costimulatory B7 - H1 in renal cell carcinoma patients: Indicator
of tumor aggressiveness and potential therapeutic target.
The response
of T cells can be controlled by
costimulatory molecules present on APC that interact with co-receptors present on the T cell.
In 2002, his group was the first to report the design
of «second - generation» CARs that, in addition to a binding domain outside
of the T cell and a signaling domain inside, included a
costimulatory domain designed to promote cell proliferation and survival.
Costimulatory and coinhibitory pathways together with metabolic pathways orchestrate the fate
of lymphocytes after antigenic stimulation.
Dr. Freeman's laboratory focuses on the identification and function
of T cell
costimulatory and coinhibitory pathways in regulating T cell activation and application
of this knowledge to the development
of more effective immunotherapies for cancer, infections, asthma, and autoimmune diseases.
We are currently investigating the role
of various T - cell
costimulatory pathways in regulating the humoral and cellular responses to and between DENV and ZIKV, and are defining the particular pathways that should be targeted to maximize safety and efficacy
of vaccines.
CpG stimulation
of precursor B lineage acute lymphoblastic leukemia induces a distinct change in
costimulatory molecule expression and shifts allogeneic T cells towards a Th1 response.